Autoimmune Retinopathy: Intravenous Immunoglobulin Treatment vs. Natural History
Publication information:
Cox J, Minkus C, Li A, Han S, Liu R, Shah P, Stanwyck L, Rizzo J, Sobrin L. Autoimmune Retinopathy: Intravenous Immunoglobulin Treatment vs. Natural History.
Ophthalmol Retina. 2024; PMID: 38428458
Abstract
This case-control study compared autoimmune retinopathy (AIR) outcomes in patients treated with intravenous immunoglobulin (IVIg) vs. those with no therapy. IVIg was associated with preservation of visual acuity and electroretinography parameters at longer term follow-up.